Sarah Cutler Benzing, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2717 Gaston Farm Rd, Chester, SC 29706 Phone: 803-374-6255 |
News Archive
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced that it has initiated a Phase IIb trial of its drug candidate IPX159 in patients with moderate to severe Restless Legs Syndrome.
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
Dicom Systems today announced the release of its newest product, DCMSYS Interface WebBridge, at the 100th annual RSNA Meeting held November 30th through December 5th at McCormick Place, Chicago, Illinois.
Researchers at University of the Pacific have developed a biochemical trick that can significantly extend the lifespan of peptides, smaller cousins of proteins. The finding opens up new possibilities for creating peptides to treat cancer, infertility and other conditions.
A specific pattern of neuronal firing in a brain reward circuit instantly rendered mice vulnerable to depression-like behavior induced by acute severe stress, a study supported by the National Institutes of Health has found. When researchers used a high-tech method to mimic the pattern, previously resilient mice instantly succumbed to a depression-like syndrome of social withdrawal and reduced pleasure-seeking - they avoided other animals and lost their sweet tooth.
› Verified 2 days ago